The Craziest Immunotherapy We've Ever Seen + CNS Gene Therapy Boom

Asgard's AT-108 might be the most insane immunotherapy of 2026. .. a first-in-class in vivo cell reprogramming play for cancer. Meanwhile, CNS gene therapy is having a moment: AviadoBio is crossing the blood-brain barrier, Avista's AI-designed capsids are heading to the eye and CSF, and Tenaya just dropped one-year cardiac gene therapy data at ASGCT. Plus: Dr. Nicole Paulk joins live! Her work on CNS-directed AAV gene therapy for glioma puts her right at the center of where this field is heading. Live on the Biotech Voyager. (Both YouTube and Linkedin)